Urology practice company Urology Management Associates (UMA) disclosed on Monday the addition of Derek Grimes as senior vice president of its Clinical Research at New Jersey Urology (NJU).
Effective April 2019, Grimes will lead the company's Clinical Research Organization (CRO), oversee operational site functions, profit and loss, clinical management and recruitment as well as be responsible for managing and supporting client relationships in the pharmaceutical, biotech and medical device industries.
Most recently, Grimes has served as vice president of clinical operations at TKL Research in New Jersey, where he oversaw the Research Clinics division.
Previously, Grimes worked for eight years with Columbia and New York Universities in managing and developing clinical trials for the universities.
Senhwa Biosciences signs clinical supply agreement with BeOne Medicines
InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011
D3 Bio completes USD108m Series B financing round
Hemab Therapeutics announces positive Phase 2 multiple ascending dose study results for sutacimig
Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA
Champions Oncology expands bioanalytical services with new technology and leadership
Mirum Pharmaceuticals to acquire Bluejay Therapeutics for HDV treatment
Poolbeg Pharma trial to feature in major CRS research programme
PureTech clears key FDA milestone for Phase 3 development of deupirfenidone
Proteome Sciences wins third US biopharma contract for new clinical assay
Lundbeck reports results from long-term follow-up of epilepsy patients treated with bexicaserin
CARsgen Therapeutics presents CT0596 study data at 2005 ASH Annual Meeting
AsymBio starts commercial production at Shanghai Fengxian Manufacturing Base
Innovent Biologics and Takeda sign global strategic partnership